Citius Pharmaceuticals is trading at $0.43, down 7.48%; the reason for the decline remains unclear. - No fresh company-specific announcement explaining the October 19 decline was found; the latest company press release located was the October 12 investor-conference announcement. - Broader reports described a volatile technology-led session but did not link it directly to Citius. Major U.S. indices were higher, so broad-market direction does not clearly explain the decline.